A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".

Authors	Rachel Allen, Andres Brainsky, Kelly Grotzinger, Tito Roccia
Journal	PharmacoEconomics (Pharmacoeconomics) Vol. 31 Issue 1 Pg. 87-9 (Jan 2013) ISSN: 1179-2027 [Electronic] New Zealand
PMID	23329595 (Publication Type: Letter, Comment)
Chemical References	Benzoates Hydrazines Pyrazoles
Topics	Benzoates (therapeutic use) Humans Hydrazines (therapeutic use) Purpura, Thrombocytopenic, Idiopathic (drug therapy) Pyrazoles (therapeutic use) Technology Assessment, Biomedical (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!